APA (7th ed.) Citation

JH, C., HR, J., AR, J., YC, L., M, K., JS, L., & YG, E. (2018). SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma. Scientific reports, 8(1), 1677. https://doi.org/10.1038/s41598-018-20086-w

Chicago Style (17th ed.) Citation

JH, Chung, Jung HR, Jung AR, Lee YC, Kong M, Lee JS, and Eun YG. "SOX2 Activation Predicts Prognosis in Patients with Head and Neck Squamous Cell Carcinoma." Scientific Reports 8, no. 1 (2018): 1677. https://doi.org/10.1038/s41598-018-20086-w.

MLA (9th ed.) Citation

JH, Chung, et al. "SOX2 Activation Predicts Prognosis in Patients with Head and Neck Squamous Cell Carcinoma." Scientific Reports, vol. 8, no. 1, 2018, p. 1677, https://doi.org/10.1038/s41598-018-20086-w.